On January 3, 2025, the Company, through its affiliate, acquired Whitecap Biosciences, LLC, (Whitecap Biosciences) for an upfront payment of approximately $ 28 million
utable to the increase in our operating results, as previously discussed. Investing Activities Net cash used in investing activities was $130 million and $116 million for the three months ended March…
Bausch + Lomb Corporation Debt Obligations
Instrument
Description
Confidence
Evidence
BLCO-DEBT
Debt stack $5.1B
90%
Market cache reports total debt of $5.1B.
Bausch + Lomb Corporation Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Bausch + Lomb Corporation.
Bausch + Lomb Corporation Ownership
Holder
Name
Confidence
Evidence
BLCO-OWNER-OAKTREE-CAPITAL-MANAGEMENT-LP
OAKTREE CAPITAL MANAGEMENT LP
90%
13F overlay lists OAKTREE CAPITAL MANAGEMENT LP as top holder; 96 tracked holders.